Rheumatic Diseases clinical trials

Explore recruiting rheumatic diseases clinical trials.

Recruiting rheumatic diseases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rheumatic Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double blind, randomised, placebo-controlled trial evaluating the efficacy and safety of nerandomilast over at least 26 weeks in patients with Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Diseases (SARD-ILD)

Netherlands, Germany, France, Spain, Italy, Austria +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

REDO-JAK: Dose REDuction Of JAnus Kinase inhibitors in patients with inflammatory rheumatic diseases

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the RSV immune response.

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Characterization of the immune response in immunosuppressed patients with rheumatic diseases, including to the recombinant zoster vaccine

France

Therapeutic use (Phase IV) EU CTIS Study details

Early recognition of progressive lung fibrosis in systemic rheumatic diseases: a characterization of the pulmonary environment through extracellular vesicles, advanced and functional imaging

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with inflammatory rheumatic diseases based on the use of carotid ultrasound.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Rheumatic Diseases trials by city

Rheumatic Diseases in Toronto Rheumatic Diseases in Vancouver Rheumatic Diseases in Montreal Rheumatic Diseases in Calgary Rheumatic Diseases in Edmonton Rheumatic Diseases in Ottawa Rheumatic Diseases in Winnipeg Rheumatic Diseases in Quebec City Rheumatic Diseases in Hamilton Rheumatic Diseases in Kitchener Rheumatic Diseases in London Rheumatic Diseases in Halifax Rheumatic Diseases in New York Rheumatic Diseases in Los Angeles Rheumatic Diseases in Chicago Rheumatic Diseases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease